Human immunodeficiency virus-associated neurocognitive disorder: Pathophysiology in relation to drug addiction

Annals of the New York Academy of Sciences

Volumn 1187, Issue , 2010, Pages 122-128

  Nath, Avindra ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Addiction; Brain; Drug abuse; HIV; Pathophysiology

Indexed keywords

COCAINE; METHAMPHETAMINE; OPIATE;

BASAL GANGLION; BLOOD BRAIN BARRIER; CELL ACTIVATION; DRUG DEPENDENCE; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; REVIEW; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RODENTIA; SIMIAE;

EID: 77949305285     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05277.x     Document Type: Review

References (68)

1. Chang, L., T. Ernst,O. Speck & C.S. Grob. 2005. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am. J. Psychiatry 162: 361-369.
2. Scott, J.C., S.P.Woods, G.E.Matt, et al. 2007. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17: 275-297.
3. Royal, W., M. Updike, O.A. Selnes, et al. 1991. HIV- 1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 41: 1905-1910.
4. Semple, S.J., J. Zians, I. Grant & T.L. Patterson. 2006. Methamphetamine use, impulsivity, and sexual risk behavior among HIV-positive menwho have sexwithmen. J. Addict. Dis. 25: 105-114.
5. Bousman,C.A., M.Cherner, C. Ake, et al. 2009.Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV. J. Affect. Disord. 119: 84-91.
6. Bell, J.E., R.P. Brettle, A. Chiswick & P. Simmonds. 1998. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121: 2043-2052.
7. Davies, J., I.P. Everall, S. Weich, et al. 1997. HIVassociated brain pathology in the United Kingdom: an epidemiological study. AIDS 11: 1145-1150.
8. Weber, R., M. Huber, M. Rickenbach, et al. 2009. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIVMed. 10: 407-416.
9. Kumar, R., C. Torres, Y. Yamamura, et al. 2004. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J. Virol. 78: 11425-11428.
10. Peterson, P.K., G. Gekker, R. Schut, et al. 1993. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv. Exp. Med. Biol. 335: 181-188.
11. Peterson, P.K., G. Gekker, S. Hu, et al. 1999. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypicalmu-opioid receptor. Neuropharmacology 38: 273-278.
12. Sundar, K.S., L.S. Kamaraju, J. Dingfelder, et al. 1995. Beta-endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. J. Neuroimmunol. 61: 97-104.
13. Chao, C.C., G. Gekker, S. Hu, et al. 1996. Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc. Natl. Acad. Sci. USA 93: 8051-8056.
14. Chao, C.C., G. Gekker, W.S. Sheng, et al. 2001. U50488 inhibits HIV-1 expression in acutely infectedmonocytederived macrophages. Drug Alcohol Depend. 62: 149-154.
15. Peterson, P.K., G. Gekker, J.R. Lokensgard, et al. 2001. Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4(+) lymphocytes. Biochem. Pharmacol. 61: 1145-1151.
16. Rogers, T.J. & P.K. Peterson. 2003. Opioid G proteincoupled receptors: signals at the crossroads of inflammation. Trends Immunol. 24: 116-121.
17. Li, Y., X.Wang, S. Tian, et al. 2002.Methadone enhances human immunodeficiency virus infection of human immune cells. J. Infect. Dis. 185: 118-122.
18. Noel, R.J. & A. Kumar. 2006. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques. Virology 346: 127-138.
19. Peterson, P.K., G. Gekker,C.C.Chao, et al. 1991.Cocaine potentiatesHIV-1 replication inhumanperipheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J. Immunol. 146: 81-84.
20. Bagasra, O. & R.J. Pomerantz. 1993. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J. Infect. Dis. 168: 1157-1164. (Pubitemid 23317129)
21. Roth, M.D., D.P. Tashkin, R. Choi, et al. 2002. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J. Infect. Dis. 185: 701-705.
22. Dhillon, N.K., R. Williams, F. Peng, et al. 2007. Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J. Neurovirol. 13: 483-495.
23. Reynolds, J.L., S.D.Mahajan, B. Bindukumar, et al. 2006. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res. 1123: 226-236.
24. Nair, M.P., S.D. Mahajan, S.A. Schwartz, et al. 2005. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J. Immunol. 174: 6617-6626.
25. Nair, M.P., Z.M. Saiyed, N. Nair, et al. 2008. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J.Neuroimmune Pharmacol. 4: 129-139.
26. Liang, H., X. Wang, H. Chen, et al. 2008. Methamphetamine enhancesHIV infection ofmacrophages.Am. J. Pathol. 172: 1617-1624.
27. Gavrilin,M.A., L.E.Mathes &M. Podell. 2002.Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J. Neurovirol. 8: 240-249.
28. Cachay, E.R., N. Moini, S.L. Kosakovsky Pond, et al. 2007. Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. Open AIDS J. 1: 5-10.
29. Everall, I., S. Salaria, E. Roberts, et al. 2005. Methamphetamine stimulates interferon inducible genes in HIV infected brain. J. Neuroimmunol. 170: 158-171.
30. Fiala, M., X.H. Gan, L. Zhang, et al. 1998. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv. Exp. Med. Biol. 437: 199-205.
31. Fiala, M., A.J. Eshleman, J. Cashman, et al. 2005. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J. Neurovirol. 11: 281-291.
32. Berger, J.R. & M. Avison. 2004. The blood brain barrier in HIV infection. Front. Biosci. 9: 2680-2685.
33. Avison, M.J., A. Nath, R. Greene-Avison, et al. 2004. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J. Neurovirol. 10: 223-232.
34. Petito, C.K. & K.S. Cash. 1992. Blood-brain barrier abnormalities in AIDS: immunohistochemical localization of serumproteins in postmortembrain. Ann. Neurol. 32: 658-666.
35. Power,C., P.A. Kong,T.O.Crawford, et al. 1993.Cerebral white matter changes in AIDS dementia: alterations of the blood-brain barrier. Ann. Neurol. 34: 339-350.
36. Andras, I.E., H. Pu, J. Tian, et al. 2005. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J. Cereb. Blood Flow Metab. 9: 1159-1170.
37. Pu, H., J. Tian, G. Flora, et al. 2003. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell Neurosci. 24: 224-237.
38. Toborek,M., Y.W. Lee,H. Pu, et al. 2003.HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem. 84: 169-179. (Pubitemid 36182077)
39. Mahajan, S.D., R. Aalinkeel, D.E. Sykes, et al. 2008. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203: 133-148.
40. Sharma, H.S. & E.A. Kiyatkin. 2009. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem.Neuroanat. 37: 18-32.
41. Lee, Y.W., B. Hennig, J. Yao & M. Toborek. 2001. Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J. Neurosci. Res. 66: 583-591.
42. Yousif, S., B. Saubamea, S. Cisternino, et al. 2008. Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein. J. Neurochem. 107: 647-657.
43. Sharma, H.S. & S.F. Ali. 2006. Alterations in blood-brain barrier function by morphine and methamphetamine. Ann. N. Y. Acad. Sci. 1074: 198-224.
44. Mahajan, S.D., R. Aalinkeel, D.E. Sykes, et al. 2008. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J. Clin. Immunol. 28: 528-541.
45. Reyes, M.G., F. Faraldi, C.S. Senseng, et al. 1991. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 82: 39-44.
46. Chang, L., D. Alicata, T. Ernst & N. Volkow. 2007. Structural and metabolic brain changes in the striatum associatedwith methamphetamine abuse.Addiction 102(Suppl. 1): 16-32.
47. Berger, J.R.&A.Nath. 1997. HIV dementia and the basal ganglia. Intervirology 40: 122-131.
48. Nath, A., M. Jones,W.Maragos, et al. 2000. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J. Psychopharmacol. 14: 222-227.
49. Nath, A.,W.Maragos, M. Avison, et al. 2001. Accelerated HIV dementia withmethamphetamine and cocaine use. J. Neurovirol. 7: 66-71.
50. Nath, A., K.F. Hauser, V. Wojna, et al. 2002. Molecular basis for interactions ofHIVand drugs of abuse. J.Acquir. Immune Defic. Syndr. 31(Suppl. 2): S62-S69.
51. Hauser, K.F., N. El-Hage, A. Stiene-Martin, et al. 2007. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J. Neurochem. 100: 567-586.
52. Ferris, M.J., C.F. Mactutus & R.M. Booze. 2008. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine systemvulnerability in NeuroAIDS. Neurosci. Biobehav. Rev. 32: 883-909.
53. Li, W., Y. Huang, R. Reid, et al. 2008. NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 28: 12190-12198.
54. Li,W., G. Li, J. Steiner&A.Nath. 2009.Role ofTat protein in HIV neuropathogenesis. Neurotox Res.16: 205-220.
55. Gurwell, J.A., A. Nath, Q. Sun, et al. 2001. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102: 555-563.
56. Turchan, J., C. Anderson, K.F. Hauser, et al. 2001. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2: 3.
57. Bruce-Keller, A.J., J. Turchan-Cholewo, E.J. Smart, et al. 2008.Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 56: 1414-1427.
58. Hauser, K.F., Y.K. Hahn, V.V. Adjan, et al. 2009. HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology. Glia 57: 194-206.
59. Kendall, S.L., C.F. Anderson, A. Nath, et al. 2005. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism. BMC Neurosci. 6: 40.
60. Harrod, S.B., C.F. Mactutus, S. Fitting, et al. 2008. Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine. Pharmacol. Biochem. Behav. 90: 723-729.
61. Aksenov, M.Y., M.V. Aksenova, A. Nath, et al. 2006. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27: 217-228.
62. Kuczenski,R., I.P. Everall, L.Crews, et al. 2007. Escalating dose-multiple bingemethamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp. Neurol. 207: 42-51.
63. Chana, G., I.P. Everall, L. Crews, et al. 2006. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67: 1486-1489.
64. Lawrence, D.M., L.C. Durham, L. Schwartz, et al. 2004. Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J. Virol. 78: 7319-7328.
65. Li, W., T.M. Malpica-Llanos, R. Gundry, et al. 2008. Nitrosative stress with HIV dementia causes decreased l-prostaglandinDsynthase activity. Neurology 70: 1753-1762.
66. Gonzalez, E., B.H. Rovin, L. Sen, et al. 2002. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 99: 13795-13800.
67. Turchan-Cholewo, J., Y. Liu, S. Gartner, et al. 2006. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and l-deprenyl. Neurobiol. Dis. 23: 109-119.
68. Turchan, J., N. Sacktor, V. Wojna, et al. 2003. Neuroprotective therapy for HIV dementia. Curr. HIV Res. 1: 373-383.